114 related articles for article (PubMed ID: 37079715)
1. Survival outcomes for patients with colorectal cancer with synchronous liver only metastasis.
Shepherdson M; Kilburn D; Ullah S; Price T; Karapetis CS; Nguyen P; Townsend A; Padbury R; Piantadosi C; Maddern G; Carruthers S; Roder D; Sorich M; Roy AC
ANZ J Surg; 2023; 93(7-8):1847-1853. PubMed ID: 37079715
[TBL] [Abstract][Full Text] [Related]
2. Trends and Outcomes of Synchronous Resection of Colorectal Metastasis in the Modern Era-Analysis of Targeted Hepatic NSQIP Database.
Jones TJ; Murphy AE; Tameron A; Hussain LR; Grannan K; Guend H; Dunki-Jacobs EM; Lee DY
J Surg Res; 2019 Jun; 238():35-40. PubMed ID: 30735964
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
[TBL] [Abstract][Full Text] [Related]
4. Stage IV rectal cancer with liver metastases: is there a benefit to resection of the primary tumor?
Cellini C; Hunt SR; Fleshman JW; Birnbaum EH; Bierhals AJ; Mutch MG
World J Surg; 2010 May; 34(5):1102-8. PubMed ID: 20177683
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis.
Martin R; Paty P; Fong Y; Grace A; Cohen A; DeMatteo R; Jarnagin W; Blumgart L
J Am Coll Surg; 2003 Aug; 197(2):233-41; discussion 241-2. PubMed ID: 12892803
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study on prognosis of neoadjuvant chemotherapy followed by hepatic surgery versus upfront surgery in patients with synchronous colorectal liver metastasis].
Wang LJ; Wang HW; Jin KM; Liu W; Bao Q; Wang K; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):248-255. PubMed ID: 34645169
[No Abstract] [Full Text] [Related]
7. Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases.
Ye LC; Liu TS; Ren L; Wei Y; Zhu DX; Zai SY; Ye QH; Yu Y; Xu B; Qin XY; Xu J
J Clin Oncol; 2013 Jun; 31(16):1931-8. PubMed ID: 23569301
[TBL] [Abstract][Full Text] [Related]
8. Impact of anatomical liver resection on patient survival in KRAS-wild-type colorectal liver metastasis: A multicenter retrospective study.
Kawai T; Ishii T; Uchida Y; Sato A; Naito S; Kitaguchi K; Komatsubara T; Nakamura I; Ogiso S; Fukumitsu K; Seo S; Fujikawa T; Yasuchika K; Hirose T; Zaima M; Taura K; Hatano E; Terajima H
Surgery; 2022 Oct; 172(4):1133-1140. PubMed ID: 35965146
[TBL] [Abstract][Full Text] [Related]
9. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM
Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540
[TBL] [Abstract][Full Text] [Related]
10. Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.
Lim C; Doussot A; Osseis M; Esposito F; Salloum C; Calderaro J; Tournigand C; Azoulay D
Clin Transl Oncol; 2018 Oct; 20(10):1274-1279. PubMed ID: 29594943
[TBL] [Abstract][Full Text] [Related]
11. Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival.
Labori KJ; Guren MG; Brudvik KW; Røsok BI; Waage A; Nesbakken A; Larsen S; Dueland S; Edwin B; Bjørnbeth BA
Colorectal Dis; 2017 Aug; 19(8):731-738. PubMed ID: 28181384
[TBL] [Abstract][Full Text] [Related]
12. Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases.
Pietrantonio F; Mazzaferro V; Miceli R; Cotsoglou C; Melotti F; Fanetti G; Perrone F; Biondani P; Muscarà C; Di Bartolomeo M; Coppa J; Maggi C; Milione M; Tamborini E; de Braud F
Med Oncol; 2015 Jul; 32(7):182. PubMed ID: 26003673
[TBL] [Abstract][Full Text] [Related]
13. Synchronous Versus Metachronous Colorectal Liver Metastasis Yields Similar Survival in Modern Era.
Wisneski AD; Jin C; Huang CY; Warren R; Hirose K; Nakakura EK; Corvera CU
J Surg Res; 2020 Dec; 256():476-485. PubMed ID: 32798995
[TBL] [Abstract][Full Text] [Related]
14. Differences in management and outcome for colon and rectal carcinoma with synchronous liver metastases: a population-based cohort study.
Båverud Olsson L; Buchli C; Villard C; Nilsson PJ
Colorectal Dis; 2021 Apr; 23(4):860-867. PubMed ID: 33259702
[TBL] [Abstract][Full Text] [Related]
15. [Treatment efficacy of surgical management for liver metastasis from colorectal cancer--a report of 198 cases].
Zhang ZG; Song C; Wang H
Ai Zheng; 2006 May; 25(5):596-8. PubMed ID: 16687081
[TBL] [Abstract][Full Text] [Related]
16. Upfront chemotherapy and short-course radiotherapy with delayed surgery for locally advanced rectal cancer with synchronous liver metastases.
Bae HW; Kim HS; Yang SY; Kim HS; Shin SJ; Chang JS; Koom WS; Kim NK
Eur J Surg Oncol; 2021 Nov; 47(11):2814-2820. PubMed ID: 34024668
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Role for Primary Tumor Location in Patients With Colorectal Liver Metastases: A Comparison of Right-Sided Colon, Left-Sided Colon, and Rectum.
Takamizawa Y; Shida D; Horie T; Tsukamoto S; Esaki M; Shimada K; Kondo T; Kanemitsu Y
Dis Colon Rectum; 2023 Feb; 66(2):233-242. PubMed ID: 35714342
[TBL] [Abstract][Full Text] [Related]
18. Liver resection rate following downsizing chemotherapy with cetuximab in metastatic colorectal cancer: UK retrospective observational study.
Malik H; Khan AZ; Berry DP; Cameron IC; Pope I; Sherlock D; Helmy S; Byrne B; Thompson M; Pulfer A; Davidson B
Eur J Surg Oncol; 2015 Apr; 41(4):499-505. PubMed ID: 25703078
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis.
Tsai MS; Su YH; Ho MC; Liang JT; Chen TP; Lai HS; Lee PH
Ann Surg Oncol; 2007 Feb; 14(2):786-94. PubMed ID: 17103254
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of Cetuximab as First-Line Therapy for Patients With Wild-Type KRAS and Unresectable Metastatic Colorectal Cancer in Real-Life Practice: Results of the EREBUS Cohort.
Rouyer M; François E; Cunha AS; Monnereau A; Noize P; Robinson P; Droz-Perroteau C; Le Monies de Sagazan A; Jové J; Lassalle R; Moore N; Fourrier-Réglat A; Smith D;
Clin Colorectal Cancer; 2018 Jun; 17(2):129-139. PubMed ID: 29523416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
